Athero Review - Issue 1/2019

Guidelines

7
Nutraceuticals with hypolipidemic effect in clinical practice: a summary statement of the International expert panel of lipidologists prepared by the committee of the Czech society for atherosclerosis

Michal Vrablík, Jan Piťha, Vladimír Bláha, Renata Cífková, Tomáš Freiberger, David Karásek, Pavel Kraml, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Zuzana Urbanová


19
An initiative to establish apheresis centers: indications for and performance of lipoprotein apheresis in the Czech Republic

Vladimír Bláha, Milan Bláha, Jan Piťha, Michal Vrablík


Reviews

30
Lysosomal acid lipase deficiency in differential diagnosis of familial hypercholesterolemia

Zuzana Urbanová, Věra Malinová


35
Therapy of dyslipidaemia in patient with muscular dystrophy: case report

Ľubica Cibičková, David Karásek

38
Severe mixed dyslipidemia as a manifestation of hematological disease: case report

Martin Šatný, Michal Vrablík, Janka Franeková, Jan Kovář

44
Psoriasis as a risk factor for cardiovascular events: case report

Branislav Vohnout, Jana Lisičanová, Andrea Havranová

49
Intensive management of dyslipidemia in very high-risk patients with PCSK9 inhibitors

Viera Doničová, Martina Gáborová


clinical studies

53
The effect of alirocumab on cardiovascular events: What did the ODYSSEY OUTCOMES Trial show?

Petr Ošťádal


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account